Prostate
Cancer Detection
Just Got Smarter
AI-powered automation that transforms prostate MRI into precise, fast + consistent insights.
Prostate cancer is the most common cancer in men and the second leading cause of cancer-related death. Over 25 million men are screened each year—yet MRI interpretation remains slow, inconsistent, and dependent on reader experience.
Acurix delivers AI-powered MRI analysis in seconds. It automates lesion detection, segmentation, and reporting—cutting annotation time by over 90% and bringing accuracy and speed to every scan.
Acurix’s advanced AI-driven platform seeks to automate MRI annotation, dramatically reducing time spent per case, enabling you to focus more on patient care and less on annotation.
Our goal is to significantly reduce variability in prostate MRI interpretations. Our AI seeks to improve accuracy and consistency, regardless of reader experience.
-
Simplify your workflow and boost diagnostic confidence. Automated lesion detection and segmentation minimize manual tasks and maximize your clinical impact.
-
Achieve operational efficiency, substantial cost savings, and enhanced diagnostic quality—all through scalable, GPU-powered cloud-based AI.
-
Streamline prostate biopsies with AI-driven insights directly integrated into your fusion biopsy platforms. Spend less time interpreting images and more time caring for patients.